Abstract
Metastatic renal cell carcinoma is associated with an unfavorable prognosis and the treatment options are limited. Adjunctive radical nephrectomy, performed either before or after the administration of systemic immunotherapy, has been proposed as a means of improving outcome. The role of nephrectomy for patients with metastatic disease remains controversial. This article reviews the role of nephrectomy in metastatic renal cell carcinoma and the optimal timing for surgery relative to immunotherapy.
Original language | English |
---|---|
Pages (from-to) | 377-381 |
Number of pages | 5 |
Journal | Current Opinion in Urology |
Volume | 9 |
Issue number | 5 |
DOIs | |
State | Published - 1999 |
ASJC Scopus subject areas
- Urology